ATLASOpus Genetics (IRD) earnings date: Nov 11, 2026
Opus Genetics (IRD) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026, before the open. Analysts expect EPS of -$0.14.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on IRD
| Last price | $3.67 (+0.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.7% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Opus Genetics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Opus Genetics reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Opus Genetics. You can switch it off at any time.
Alert me before IRD reportsFree to start. Creating an account takes under a minute.
IRD earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.14 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | -85.4% |
| Average move around a report | ±4.6% (last 4) |
| Sector | Healthcare · Biotechnology |
Opus Genetics earnings history: last 4 reports
Opus Genetics last reported on Aug 6, 2026: EPS of -$0.08 against an estimate of -$0.16 (+50.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.16 | -$0.08 | +50.0% | Beat | -3.2% |
| Jul 27, 2026 | $1.54 | $1.69 | +9.7% | Beat | +10.7% |
| May 26, 2026 | $2.34 | $3.14 | +34.2% | Beat | -2.8% |
| May 12, 2026 | -$0.14 | -$0.75 | -435.7% | Miss | -1.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for IRD
See the fair value, the probability range and the earnings history of Opus Genetics on its ATLAS page.
Opus Genetics (IRD) stock analysisPlans from €3.99 a month.
Opus Genetics earnings: frequently asked questions
When does Opus Genetics (IRD) report earnings?
Opus Genetics is scheduled to report on Wednesday, November 11, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for IRD?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.14 per share (USD). Estimates can change before the report.
How often does IRD beat earnings estimates?
Of its last 4 reports with a recorded result, Opus Genetics beat the EPS estimate 3 times; the average surprise was -85.4%. Past results do not predict the next one.
How much does IRD move around earnings?
Over its last 4 reports the stock moved an average of 4.6% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Opus Genetics beat earnings estimates last quarter?
Opus Genetics last reported on Aug 6, 2026: EPS of -$0.08 against an estimate of -$0.16 (+50.0% surprise), a beat.
How much does IRD usually move in a day?
On a normal trading day the ATLAS model puts IRD’s one-day range at about ±4.7%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer